A Polymorphism in the Protease-Like Domain of Apolipoprotein(a) Is Associated With Severe Coronary Artery Disease

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2007-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/ATVBAHA.107.141291PMID 17569884
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene Variants of VAMP8 and HNRPUL1 Are Associated With Early-Onset Myocardial Infarction

  2006cited by this paper
• Asp92Asn Polymorphism in the Myeloid IgA Fc Receptor Is Associated With Myocardial Infarction in Two Disparate Populations: CARE and WOSCOPS

  2006cited by this paper
• Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2006cited by this paper
• Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans

  2006cited by this paper
• Haploview: analysis and visualization of LD and haplotype maps

  2005cited by this paper
• [International HapMap project].

  2005cited by this paper
• Efficiency and power in genetic association studies

  2005cited by this paper
• Identification of four gene variants associated with myocardial infarction.

  2005cited by this paper
• Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.

  2005cited by this paper
• Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands

  2004cited by this paper
• A common nonsense mutation in the repetitive Kringle IV‐2 domain of human apolipoprotein(a) results in a truncated protein and low plasma Lp(a)

  2004cited by this paper
• A haplotype map of the human genome

  2003cited by this paper
• Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform?

  2003cited by this paper
• Prevalence of conventional risk factors in patients with coronary heart disease.

  2003cited by this paper
• Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions.

  2003cited by this paper
• A haplotype map of the human genome.

  2003cited by this paper
• Genetic Data Analysis II. Methods for Discrete Population Genentic Data

  2002cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Coronary Heart Disease

  2002cited by this paper
• SNP judgments and freedom of association.

  2002cited by this paper
• Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians.

  2001cited by this paper
• High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR.

  2000cited by this paper
• Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies

  2000cited by this paper
• LPA gene: interaction between the apolipoprotein(a) size (‘kringle IV’ repeat) polymorphism and a pentanucleotide repeat polymorphism influences Lp(a) lipoprotein level

  2000cited by this paper
• Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women.

  2000cited by this paper
• Multiplexed single nucleotide polymorphism genotyping by oligonucleotide ligation and flow cytometry.

  2000cited by this paper
• Contribution of apolipoprotein(a) size, pentanucleotide TTTTA repeat and C/T(+93) polymorphisms of the apo(a) gene to regulation of lipoprotein(a) plasma levels in a population of young European Caucasians.

  1999cited by this paper
• The Identification of Polymorphisms in the Coding Region of the Apolipoprotein (a) Gene

  1999cited by this paper
• Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study.

  1999cited by this paper
• Molecular basis of congenital lp(a) deficiency: a frequent apo(a) 'null' mutation in caucasians.

  1999cited by this paper
• Prediction of coronary heart disease using risk factor categories.

  1998cited by this paper
• Significant impact of the +93 C/T polymorphism in the apolipoprotein(a) gene on Lp(a) concentrations in Africans but not in Caucasians: confounding effect of linkage disequilibrium.

  1998cited by this paper
• Polymorphonuclear Cells Isolated from Human Peripheral Blood Cleave Lipoprotein(a) and Apolipoprotein(a) at Multiple Interkringle Sites via the Enzyme Elastase

  1997cited by this paper
• Structural analysis of apolipoprotein A-I: limited proteolysis of methionine-reduced and -oxidized lipid-free and lipid-bound human apo A-I.

  1997cited by this paper
• Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease.

  1996cited by this paper
• Genetic susceptibility to death from coronary heart disease in a study of twins.

  1994cited by this paper
• Molecular basis for "null" lipoprotein(a) phenotypes and the influence of apolipoprotein(a) size on plasma lipoprotein(a) level in the baboon.

  1994cited by this paper
• Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites.

  1993cited by this paper
• The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms.

  1993cited by this paper
• Genetic Data Analysis. Methods for Discrete Population Genetic Data

  1992cited by this paper
• Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.

  1992cited by this paper
• cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

  1987cited by this paper

• Whole Exome Sequencing Identifies a Novel Frameshift Mutation of the WRN Gene in a Werner Syndrome Family and Functional Analysis

  2025cites this paper
• The Lipoprotein(a) rs3798220 and rs10455872 polymorphisms and coronary heart disease: a meta-analysis of 55,647 participants.

  2025cites this paper
• Role of Aspirin in Reducing Risk for Atherosclerotic Cardiovascular Disease in Individuals with Elevated Lipoprotein(a)

  2025cites this paper
• Structure-guided dissection of the genetic variations within human LPA locus and its role in the development of cardiovascular diseases.

  2025cites this paper
• Cardiovascular Implications of Lipoprotein(a) and its Genetic Variants: A Critical Review From the Middle East.

  2025cites this paper
• Lipoprotein(a) and Chronic Kidney Disease: Insights into New Therapeutic Opportunities.

  2025cites this paper
• Ancestry specific distribution of LPA Kringle IV-Type-2 genetic variants highlight associations to apo(a) copy number, glucose, and hypertension

  2024cites this paper
• Impacts of ABCG2 loss of function variant (p. Gln141Lys, c.421 C > A, rs2231142) on lipid levels and statin efficiency: a systematic review and meta-analysis

  2024cites this paper
• Aspirin use in patients with elevated Lipoprotein(a): Impact on cardiovascular events and bleeding.

  2024cites this paper
• Variation in lipoprotein(a) response to potent lipid lowering: The role of apolipoprotein (a) isoform size.

  2024cites this paper
• Association of the LPA gene polymorphisms with coronary artery disease risk in the Xinjiang population of China: A case–control study

  2023cites this paper
• Lipoprotein(a): Just an Innocent Bystander in Arterial Hypertension?

  2023cites this paper
• Supporting evidence for lipoprotein(a) measurements in clinical practice.

  2023cites this paper
• Characteristics and lipid lowering treatment patterns in patients tested for lipoprotein(a): A real-world US study

  2023cites this paper
• High levels of lipoprotein(a) in transgenic mice exacerbate atherosclerosis and promote vulnerable plaque features in a sex-specific manner.

  2023cites this paper
• Association of FHL5 and LPA genetic polymorphisms with diabetes mellitus risk: a case-control study

  2023cites this paper
• Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene

  2022cites this paper
• Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis.

  2022cites this paper
• Causal associations between disorders of lipoprotein metabolism and ten cardiovascular diseases

  2022cites this paper
• Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes.

  2022cites this paper
• Association of lipoprotein(a) with all-cause and cause-specific mortality: A prospective cohort study.

  2022cites this paper
• CALM1 rs3179089 polymorphism might contribute to coronary artery disease susceptibility in Chinese male: a case–control study

  2021cites this paper
• Lack of Association of LPA Gene Polymorphisms with Coronary Artery Disease in Pakistani Subjects

  2021influential citation
• Comparative Analysis on Single- and Multiherb Strategies in Coronary Artery Atherosclerosis Therapy

  2021cites this paper
• Prevalence and influence of LPA gene variants and isoform size on the Lp(a)-lowering effect of pelacarsen.

  2021cites this paper
• Genetics and Genomics of Atherosclerotic Cardiovascular Disease

  2020cites this paper
• Lipoprotein(a) and Cardiovascular Disease.

  2020cites this paper
• Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?

  2020cites this paper
• The Association of SNPs Located in the CDKN2B-AS1 and LPA Genes With Carotid Artery Stenosis and Atherogenic Stroke

  2019cites this paper
• Lipoprotein(a) levels and the risk of myocardial infarction among seven ethnic groups

  2019cites this paper
• Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups

  2019cites this paper
• Cohort profile: The LipidCardio Study - Role of Lipoproteins in Cardiovascular Disease

  2019cites this paper
• There is an association between a genetic polymorphism in the ZNF259 gene involved in lipid metabolism and coronary artery disease.

  2019cites this paper
• Investigation of LPA sequence variants rs6415084, rs3798220 with conventional coronary artery disease in Iranian CAD patients

  2019cites this paper
• Lp(a) and PCSK9 : From concept to clinical practice

  2019cites this paper
• Cohort profile: role of lipoproteins in cardiovascular disease—the LipidCardio study

  2019cites this paper
• Effect of antiretroviral therapy on allele-associated Lp(a) level in women with HIV in the Women’s Interagency HIV Study[S]

  2018cites this paper
• Association of ABCG2 polymorphisms with ischemic stroke in a Chinese population

  2018cites this paper
• Lipoprotein(a) in clinical practice: New perspectives from basic and translational science

  2018cites this paper
• South Asian Cardiovascular Disease & Cancer Risk: Genetics & Pathophysiology

  2018cites this paper
• Werner syndrome (WRN) gene variants and their association with altered function and age-associated diseases.

  2018cites this paper
• The association of polymorphic variants, rs2267788, rs1333049 and rs2383207 with coronary artery disease, its severity and presentation in North Indian population.

  2018cites this paper
• Lipoprotein(a): A missing culprit in the management of athero‐thrombosis?

  2018cites this paper
• LPA Gene, Ethnicity, and Cardiovascular Events

  2017cites this paper
• Multiple thrombophilia mutations as a possible cause of premature myocardial infarction

  2017cites this paper
• Nutritional, hormonal and genetic factors in the development of overeating tendency toward food addiction

  2017cites this paper
• Lp(a) in Childhood

  2017cites this paper
• Characterization of the I4399M variant of apolipoprotein(a): implications for altered prothrombotic properties of lipoprotein(a)

  2017cites this paper
• The Genetic Architecture of Coronary Artery Disease: Current Knowledge and Future Opportunities

  2017cites this paper
• Temporal variability in lipoprotein(a) levels in patients enrolled in the placebo arms of IONIS-APO(a)Rx and IONIS-APO(a)-LRx antisense oligonucleotide clinical trials.

  2017cites this paper
• Expression of Genes and Their Polymorphism Influences the Risk of Knee Osteoarthritis

  2017cites this paper
• Lipoprotein (a) Evolution: Possible Benefits and Harm. Genetic and Non-Genetic Factors Influencing its Plasma Levels.

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Identification and targeting of genes in atherosclerosis

  2017cites this paper
• Editorial: Lipoprotein (a), More than Just Cholesterol?

  2017cites this paper
• Structure, function, and genetics of lipoprotein (a)

  2016cites this paper
• Functional Variant in the SLC22A3-LPAL2-LPA Gene Cluster Contributes to the Severity of Coronary Artery Disease

  2016cites this paper
• New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs.

  2016cites this paper
• Investigation of associations between ten polymorphisms and the risk of coronary artery disease in Southern Han Chinese

  2016cites this paper
• Lipoprotein(a): novel target and emergence of novel therapies to lower cardiovascular disease risk

  2016cites this paper
• Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis

  2016cites this paper
• Lipoprotein (a): impact by ethnicity and environmental and medical conditions

  2016cites this paper
• Testing Population-Specific Quantitative Trait Associations for Clinical Outcome Relevance in a Biorepository Linked to Electronic Health Records: LPA and Myocardial Infarction in African Americans

  2016cites this paper
• Роль липопротеина (а) в развитии ишемического инсульта и других сердечно-сосудистых заболеваний

  2016cites this paper
• Population and assay thresholds for the predictive value of lipoprotein (a) for coronary artery disease: the EPIC-Norfolk Prospective Population Study1

  2016cites this paper
• Elevated Lipoprotein(a) Levels, LPA Risk Genotypes, and Increased Risk of Heart Failure in the General Population.

  2016cites this paper
• Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials.

  2016cites this paper
• Oxidative Modifications of Apolipoprotein(a): Implications for Proinflammatory and Prothrombotic Roles of Lipoprotein(a) in the Vasculature

  2016cites this paper
• Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?

  2016cites this paper
• A coronary artery disease-associated SNP rs6903956 contributed to asymptomatic hyperuricemia susceptibility in Han Chinese

  2015cites this paper
• Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study.

  2015cites this paper
• Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels.

  2015cites this paper
• Genetic Risk Factors and Mendelian Randomization in Cardiovascular Disease

  2015cites this paper
• Know Your Risk — Is it Time for a Paradigm Shift ?

  2015influential citation
• Genetics of inflammatory mediators, in particular interleukin 6 and selenoprotein S, that have a role in coronary artery disease.

  2015influential citation
• Scalable Feature Selection Applications for Genome-Wide Association Studies of Complex Diseases

  2015influential citation
• Functional analysis of novel genetic markers of coronary artery disease identified by genome-wide association studies

  2015cites this paper
• Lack of association of rs3798220 with small apolipoprotein(a) isoforms and high lipoprotein(a) levels in East and Southeast Asians.

  2015cites this paper
• Associations of the uric acid related genetic variants in SLC2A9 and ABCG2 loci with coronary heart disease risk

  2015cites this paper
• A Common LPA Null Allele Associates With Lower Lipoprotein(a) Levels and Coronary Artery Disease Risk

  2014cites this paper
• [Clinical significance of and treatment options for increased lipoprotein(a)].

  2014cites this paper
• LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography

  2014cites this paper
• The Association between the LPA Gene Polymorphism and Coronary Artery Disease in Chinese Han Population

  2014cites this paper
• Type-2 diabetes and coronary heart disease: common physiopathology, viewed from autoimmunity

  2014influential citation
• Low "quotient" Lp(a) concentration mediates autoimmune activation and independently predicts cardiometabolic risk.

  2014cites this paper
• No large-effect low-frequency coding variation found for myocardial infarction.

  2014influential citation
• Genetic Variants Associated with Myocardial Infarction and the Risk Factors in Chinese Population

  2014cites this paper
• Antiplatelet therapies: aspirin at the heart of new directions.

  2014cites this paper
• Lipoprotein (a), LPA Ile4399Met, and fibrin clot properties.

  2014cites this paper
• Inherited arrhythmia syndromes: exome sequencing opens a new door to diagnosis.

  2014cites this paper
• What is the ultimate test that lowering lipoprotein(a) is beneficial for cardiovascular disease and aortic stenosis?

  2014cites this paper
• Lipoprotein(a): an important cardiovascular risk factor and a clinical conundrum.

  2014cites this paper
• ANALYSIS OF PATHWAYS AND NETWORKS INFLUENCING THE DIFFERENTIAL EXPRESSION OF GENES IN CORONARY ARTERY DISEASE

  2014cites this paper
• Beyond the Standard Lipid Profile: What is Known about Apolipoproteins, Lp(a), and Lipoprotein Particle Distributions in Children

  2014cites this paper
• Genetic Testing for Lipoprotein(a) Variant(s) as a Decision Aid for Aspirin Treatment

  2014cites this paper
• Genetics of Lipoprotein(a) in Relation to Coronary Heart Disease

  2013cites this paper
• Positive correlation between variants of lipid metabolism-related genes and coronary heart disease

  2013cites this paper
• Lipoprotein(a), cardiovascular disease, and contemporary management.

  2013cites this paper
• Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)1

  2013cites this paper
• Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention

  2013cites this paper
• Two Rare Variants Explain Association with Acute Myocardial Infarction in an Extended Genomic Region Including the Apolipoprotein(A) Gene

  2013influential citation